UrgoStart® Plus Pad is an innovative, patented dressing developed by Urgo Medical composed of two exclusive technologies, TLC-NOSF Healing Matrix (NOSF* impregnated in a TLC Healing Matrix) and poly-absorbent fibres.

FEATURES:

• Healing properties
• Comfort and ease of use

BENEFITS:

• Reduction of healing time combined with cleaning (slough, exudate, debris).
• Absorption of exudate
• Management of minor bleeding wounds
• Creation and maintenance of a moist wound environment that promotes healing
• Atraumatic removal
• Protection of peri-wound skin
• Pain free removal
• One piece removal of the dressing
• Very conformable and easy to reposition

INDICATIONS:

UrgoStart^® Plus Pad is indicated for all stages (from the desloughing stage to complete healing) of:

• Exuding wounds
• Chronic wounds
  • Leg ulcers
  • Pressure injuries
  • Diabetic foot ulcers
• Long standing acute wounds.

CONTRAINDICATIONS:

• UrgoStart® Plus Pad facilitates the management of minor bleeding wounds. However it should not be used for heavily bleeding wounds.
• In order not to delay any optimal treatment, UrgoStart® Plus Pad is contra-indicated in cancerous wounds and fistula wounds which may reveal a deep abscess.
• Do not use when there is a known sensitivity to UrgoStart® Plus Pad.

PRECAUTIONS:

• The soft-adherent layer of UrgoStart® Plus Pad adheres to latex surgical gloves. Therefore it is recommended that the tabs be used to facilitate application of the dressing.
• If the wound shows signs of local infection, it is recommended that anti-microbial treatment is used first before starting treatment with UrgoStart® Plus Pad.
• If an atypical ulcer presents induration or over-granulation, treatment with UrgoStart® Plus Pad should only be initiated after verifying that ulcer deterioration is absent, to prevent any delay in diagnosis.
• In the absence of clinical data regarding Epidermolysis Bullosa (even for longstanding lesions), the use of UrgoStart® Plus Pad is not recommended.
• Stinging or even painful sensations may be reported at the start of the treatment. These are usually linked to the healing process and the need to suspend treatment is rare.
• During desloughing, the wound may appear to get larger due to the gradual elimination of slough.
• Concomitant use with a cream, an ointment, an emulsion is not recommended.
• UrgoStart® Plus Pad must not be used in a hyperbaric chamber.
• Sterile individual packaging, for single use only: re-using a disposable dressing can lead to the risks of infection.
  • Do not re-sterilise the dressing.
  • (*) Check that the sterile protector is intact before use. Do not use if
    package is damaged.

DIRECTIONS FOR USE:

For Highly exudating wounds:

CUTTING GUIDE: